Literature DB >> 33523446

TCR/ITK Signaling in Type 1 Regulatory T cells.

Michael C McGee1, Avery August2, Weishan Huang3,4.   

Abstract

Type 1 regulatory T (Tr1) cells can modulate inflammation through multiple direct and indirect molecular and cellular mechanisms and have demonstrated potential for anti-inflammatory therapies. Tr1 cells do not express the master transcription factor of conventional regulatory T cells, Foxp3, but express high levels of the immunomodulatory cytokine, IL-10. IL-2-inducible T-cell kinase (ITK) is conserved between mouse and human and is highly expressed in T cells. ITK signaling downstream of the T-cell receptor (TCR) is critical for T-cell subset differentiation and function. Upon activation by TCR, ITK is critical for Ras activation, leading to downstream activation of MAPKs and upregulation of IRF4, which further enable Tr1 cell differentiation and suppressive function. We summarize here the structure, signaling pathway, and function of ITK in T-cell lineage designation, with an emphasis on Tr1 cell development and function.

Entities:  

Keywords:  IRF4; ITK; Ras; TCR; Tr1 cells

Mesh:

Substances:

Year:  2021        PMID: 33523446     DOI: 10.1007/978-981-15-6407-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  76 in total

Review 1.  Regulation of T-cell responses and disease by tec kinase Itk.

Authors:  Avery August; Melanie J Ragin
Journal:  Int Rev Immunol       Date:  2012-04       Impact factor: 5.311

Review 2.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

3.  In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness.

Authors:  Roxana Roohi Ahangarani; Wim Janssens; Luc VanderElst; Vincent Carlier; Thierry VandenDriessche; Marinee Chuah; Birgit Weynand; Jeroen A J Vanoirbeek; Marc Jacquemin; Jean-Marie Saint-Remy
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

4.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.

Authors:  C L Bennett; M E Brunkow; F Ramsdell; K C O'Briant; Q Zhu; R L Fuleihan; A O Shigeoka; H D Ochs; P F Chance
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

Review 5.  The Tec family of tyrosine kinases in T cells, amplifiers of T cell receptor signals.

Authors:  Avery August; Angela Fischer; Shengli Hao; Cynthia Mueller; Melanie Ragin
Journal:  Int J Biochem Cell Biol       Date:  2002-10       Impact factor: 5.085

6.  The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

Authors:  Lionel Apetoh; Francisco J Quintana; Caroline Pot; Nicole Joller; Sheng Xiao; Deepak Kumar; Evan J Burns; David H Sherr; Howard L Weiner; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

7.  Cutting edge: Itk-dependent signals required for CD4+ T cells to exert, but not gain, Th2 effector function.

Authors:  Byron B Au-Yeung; Shoshana D Katzman; Deborah J Fowell
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 8.  T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches.

Authors:  Mübeccel Akdis
Journal:  Expert Opin Biol Ther       Date:  2008-06       Impact factor: 4.388

9.  Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase.

Authors:  A August; A Sadra; B Dupont; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

10.  Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells.

Authors:  Rosa Bacchetta; Barbarella Lucarelli; Claudia Sartirana; Silvia Gregori; Maria T Lupo Stanghellini; Patrick Miqueu; Stefan Tomiuk; Maria Hernandez-Fuentes; Monica E Gianolini; Raffaella Greco; Massimo Bernardi; Elisabetta Zappone; Silvano Rossini; Uwe Janssen; Alessandro Ambrosi; Monica Salomoni; Jacopo Peccatori; Fabio Ciceri; Maria-Grazia Roncarolo
Journal:  Front Immunol       Date:  2014-01-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.